January 07, 2025 03:46 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Delhi assembly elections on Feb 5, results on Feb 8 | Allu Arjun visits boy injured during Pushpa 2 stampede in Hyderabad | Donald Trump repeats his US-Canada merger offer after Justin Trudeau's resignation | India's HMPV cases surge to 7 after two cases reported from Nagpur | H-1B visa renewal will get simpler in 2025, Indians to benefit most as home country travel won't be required | As India detects 3 HMPV cases, #lockdown trends; Centre says no need to panic | Justin Trudeau announces resignation as Canada's PM amid rising pressure by partymates | 8 jawans, driver killed as Maoists blow up security vehicle in Chhattisgarh's Bijapur | Atul Subhash suicide: Karnataka High Court refuses to quash FIR against wife Nikita Singhania | Delhi elections: Congress launches Pyari Didi scheme promising Rs. 2,500 per month to women residents
COVID-19
Image Credit: UNI

India reports 41,195 new COVID-19 cases in 24 hours

| @indiablooms | Aug 12, 2021, at 04:27 pm

New Delhi/IBNS: In another spike in daily COVID-19 cases, India Thursday reported 41,195 new infections while the toll went up by 490 in the last 24 hours.

The country in the same period achieved the highest ever recovery rate, which is 97.45%, with 39,069 coronavirus patients recovering in 24 hours between Wednesday and Thursday mornings.

So far in the country, which was devastated by the second COVID-19 wave, 3,12,60,050 coronavirus patients have recovered.

The Union Health Ministry in its bulletin stated 52.36 crore anti-COVID-19 vaccine doses have been administered in the country of 1.3 billion people.

Meanwhile, the Drugs Controller General Of India (DCGI) has given its nod to a study on mixing Covishield and Covaxin, the two main vaccines used in India's COVID-19 vaccination programme.

A Subject Expert Committee of the Central Drugs Standard Control Organisation (CDSCO) had recommended such a study on Jul 29.

This study would be different from the one conducted by Indian Council of Medical Research (ICMR).

ICMR studied 18 people, 11 male, and seven female with a median age of 62 years, in Uttar Pradesh in India who received Covishield as the first dose followed by inadvertent administration of Covaxin, said the report.

The study revealed that vaccination with a combination of an adenovirus vector platform-based vaccine followed by an inactivated whole virus vaccine was not only safe but also triggered better immunogenicity, the top health body said.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.